<DOC>
	<DOCNO>NCT00535938</DOCNO>
	<brief_summary>The MOBILITY Project prospective , non-randomized , observational , multi-centre evaluation Health Utility via SF-12速 Health Survey Scores SF-6D patient receive BOTOX速 therapeutic use .</brief_summary>
	<brief_title>MDs Botox Utility ( MOBILITY )</brief_title>
	<detailed_description />
	<mesh_term>Strabismus</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Blepharospasm</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients eligible BOTOX速 treatment deem medically necessary physician Patient ( and/or patient 's authorized legal representative ) provide write informed consent ; patient age 18 must review sign Patient Assent Form Patients age 14 Patient participate clinical trial BOTOX速 indication Patient contraindication use botulinum toxin A</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>